VALBENAZINE (has an active metabolite) | VALBENAZINE | ATC N07XX13
NERVOUS SYSTEM VESICULAR MONOAMINE TRANSPORTER 2 (VMAT2) INHIBITOR (KI = 150 NANOMOLAR) TREATMENT OF ADULTS WITH TARDIVE DYSKINESIA | ORAL | Tmax 0.75 HOUR F 49 PERCENT VD 92 LITER PPB 99 PERCENT Cl 7.2 LITER / HOUR HT 15 HOUR SOLUBILITY SLIGHTLY SOLUBLE IN WATER | VESICULAR MONOAMINE TRANSPORTER 2 (VMAT2) | Synaptic vesicular amine transporter UNIPROT Q05940 SLC18A2 more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |